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Abstract
Liver perisinusoidal fat-storing cells (FSC) show morphologi-
cal and ultrastructural characteristics similar to pericytes regu-
lating local blood flow in other organs. In the present study we
have analyzed whether FSC respond to local vasoconstrictors
such as thrombin, angiotensin-II, and endothelin-1 with an in-
crease in intracellular free calcium concentration (ICa2I1I) cou-
pled with effective cell contraction. All agonists tested induced
a rapid and dose-dependent increase in ICa2`i1 followed by a
sustained phase lasting several minutes in confluent mono-
layers of Fura-2-loaded human FSC. Pharmacological studies
performed using different Ca2+ channel blockers indicated that,
at least for thrombin and angiotensin-II, the sustained phase is
due to the opening of voltage-sensitive membrane Ca2" chan-
nels. To analyze the temporal and spatial dynamics of Ca2"
release in response to these agonists, we performed experi-
ments on individual Fura-2-loaded human FSC using a dual
wavelength, ratiometric video imaging system. The rise in
ICa2"], was exclusively localized to the cytoplasm, particularly
in the branching processes. Increases in ICa2"1, more than four-
fold were associated with a simultaneous and transient reduc-
tion of cell area indicating reversible cell contraction. Our re-
sults indicate that the Ca2"-dependent contraction of human
FSC in vitro may reflect a potential role in regulating sinusoidal
blood flow in vivo. (J. Clin. Invest. 1992. 90:642-646.) Key
words: fat-storing cells * intracellular free calcium * cell contrac-
tion * thrombin * angiotensin-II * endothelin-1
Introduction
Liver fat-storing cells (FSC1; also known as perisinusoidal stel-
late cells, lipocytes, Ito cells) have recently been shown to play
important roles in retinol metabolism and hepatic fibrogenesis
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(for review see 1, 2). A possible role of FSC as liver-specific
pericytes has also been hypothesized (1-3). Indeed, FSC show
morphological and ultrastructural characteristics similar to
pericytes regulating blood flow in other organs. These include:
perisinusoidal and interhepatocellular branching processes
containing massive 5-nm actin-like filaments and encircling
neighboring sinusoids (4), a contact surface between stellate
cells and nerve endings (5), and the expression ofthe a-smooth
muscle actin gene (6).
The present study was undertaken to verify whether FSC,
like other perivascular contractile cells, respond to local vaso-
constrictors such as thrombin, endothelin- 1, and angiotensin-
II. For this purpose, we have analyzed the variations of intra-
cellular free calcium concentration ([Ca2]ji) in monolayers and
in individual agonist-stimulated FSC isolated from normal hu-
man liver. In addition, we have studied the reversible changes
of cell area coupled with agonist-stimulated intracellular cal-
cium transients by using a dynamic video imaging technique of
cellular fluorescence.
Methods
Isolation, culture, and characterization ofhuman FSC. Human FSC
were isolated from wedge sections of normal human liver unsuitable
for transplantation. After extensive washings in saline, liver tissue was
finely minced using a razor blade, placed in a sterile flask containing
0.5% pronase (103 proteolytic U/mg; Calbiochem Corp., San Diego,
CA), 0.05% type IV collagenase (Sigma Chemical Co., St. Louis, MO),
and 10 Ag/ml of DNAse (bovine pancreas; Calbiochem) in 100 ml of
HBSS without calcium and magnesium, and agitated at 370C for 30
min. The resulting cell suspension was filtered through a 105-Mm nylon
gauze. The undigested tissue retained into the gauze was further di-
gested using 0.05% pronase, filtered, and pooled with the remainder of
the cell suspension. The combined digest was washed four times at 450
g for 10 min in HBSS containing 10 Mg/ml of DNAse and the final
pellet was finally resuspended in 25 ml ofthe same solution. FSC were
separated from other liver nonparenchymal cells by ultracentrifugation
over gradients of stractan (Larex-LO; Larex International Co., Ta-
coma, WA) as described elsewhere (7, 8). FSC were recovered from the
interface between the 1.053 stractan gradient and the medium. Cells
recovered at this level (1.4 X 106 cells/g oftissue) were highly viable and
- 90% pure.
Cells were cultured in Iscove's modified Dulbecco's medium
(Gibco Laboratories, Grand Island, NY) supplemented with 0.6 U/ml
insulin, 2 mM glutamine, 0.1 mM nonessential amino acids, 1 mM
1. Abbreviations used in this paper: AII, angiotensin-II; [Ca2"],, extra-
cellular calcium; [Ca2+]i, intracellular free calcium concentration; ET-
1, endothelin-l; FSC, fat-storing cells; KHH, Krebs-Henseleit-Hepes;
SFIF, serum-free insulin-free; THR, thrombin.
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sodium pyruvate, antibiotic antifungal solution, and 20% fetal bovine
serum. Experiments described in this study were performed on cells
between first and second passage using two individual cell lines. Hu-
man FSC in primary culture were identified by immunostaining for
intermediate filaments, surface antigens, and by transmission electron
microscopy. Cells plated onto sterile tissue culture chambers (Lab-tek
Div., Miles Laboratories Inc., Naperville, IL) were washed twice with
PBS, dried overnight at room temperature, and fixed in acetone at 4VC
for 5 min. Monoclonal antibodies specific for vimentin (V9; Dako-
patts, Glostrup, Denmark), a-smooth muscle actin (1A4; BioGenex,
San Ramon, CA) human desmin (D-33; Dakopatts), pan-cytokeratin
(Lu5; Boehringer Mannheim GmbH, Mannheim, Germany), Ki-M I P,
directed against the monocyte/macrophageantigenCD68 (9), and poly-
clonal antibodies against factor VIII-related antigen (Dakopatts), and
porcine desmin (Sigma Chemical Co.) were applied onto cells and de-
tected with the alkaline anti-phosphatase anti-alkaline phosphatase
(APAAP) method (10). Cells demonstrated intense staining for vimen-
tin, and slightly for a-smooth muscle actin and porcine desmin. The
negative staining for CD-68, factor VIII-related antigens, and cytokera-
tin, demonstrated the absence of contaminating mono/macrophagic,
endothelial, and epithelial cells, respectively. Transmission electron mi-
croscopy studies, performed as described elsewhere (1 1), revealed the
presence of numerous large lipid droplets in the cytoplasm associated
with abundant bundles of myofilaments.
Fluorimetric analysis of intracellular free calcium in human FSC
monolayers. Human FSC were grown to confluence on 14 X 14 mm
plastic (Aclar, Pottsville, PA) cover slips in complete culture medium,
and then incubated in serum-free insulin-free (SFIF) medium for 24 h.
Loading of the cells with the fluorescent Ca2" indicator Fura-2-AM
(Calbiochem) was achieved by incubating the cells for 45 min at 370C
with 1 MM Fura-2-AM. The loading medium was then replaced with 1
ml offresh SFIF medium and the cells were incubated for additional 20
min at 370C, followed by rinsing with ice-cold Krebs-Henseleit-Hepes
(KHH) containing (in mM): Na+ 140.7, K+ 5.3, Cl- 132.4, Ca2+ 1.0,
Mg2' 0.81, glucose 5.5, Hepes 20.3, with 0.1% fatty acid-free bovine
serum albumin, pH 7.4. The cover slips were placed diagonally in a
square quartz cuvette so that the excitation and emission paths were at
a 450 angle to the cover slip. The cuvette, containing 2 ml of KHH
buffer, was maintained at 37°C. Thrombin (THR; from human
plasma, Boehringer Mannheim) endothelin-l (ET-l; Novabiochem
AG, Llufelfingen, Switzerland) or angiotensin-II (All; Novabiochem)
were directly added to the cuvette, and fluorescence was continuously
recorded, under constant stirring, by a Johnson Foundation Biomedi-
cal Instrumentation Group fluorometer (Philadelphia, PA) using a sin-
gle-wavelength excitation (340 nm)/emission (500 nm). In some exper-
iments, cell monolayers were pretreated with 3 mM EGTA (Sigma) or
with two Ca2+ channel blockers, namely bepridil and nifedipine (both
purchased from Calbiochem). Calibration was performed for each
cover slip as indicated elsewhere (12). Cell autofluorescence was evalu-
ated in parallel cover slips both by measuring fluorescence ofunloaded
cells and by quenching Fura-2 fluorescence with 1 mM MnCI2 after the
addition ofionomycin. In both cases cell autofluorescence was negligi-
ble and, in addition, it was not modified by addition ofthe agonists, as
measured in monolayers not loaded with Fura-2.
Digital video imaging of intracellular free calcium in individual
FSC. For these experiments human FSC were seeded at low density
and grown in complete culture medium on round glass cover slips (25
mm diameter, 0.2 mm thick) for 72 h, and then incubated for 24 h in
SFIF medium. Cells were loaded with 10 ,M Fura-2-AM in Hepes-
NaHCO3 buffer containing 140 mM NaCl, 3 mM KCI, 0.5 mM
NaH2PO4, 12 mM NaHCO3, 1.2 mM MgCI2, 10 mM Hepes, 10 mM
glucose, with 0.1% fatty acid-free bovine serum albumine, pH 7.4, at
37°C for 45 min (13). After loading, the cover slips were washed and
stored at room temperature until used (always < 45 min after loading).
The cover slips were then placed in a perfusion chamber mounted on
the stage of a Diaphot-TMD epifluorescence inverted microscope (Ni-
kon Co., Tokyo, Japan) equipped with a xenon lamp. Fura-2-loaded
cells were visualized with a Nikon CF x 100 oil immersion or x40
objectives (Nikon Co.). A filter cassette with a dichroic mirror (DM
400) and a barrier filter (BA 510) were used. Excitation wavelengths
were alternated between 340 and 380 nm with an automated filter
changer. Neutral density filters were used to diminish Fura-2 photob-
leaching. Video images were obtained with an extended ISIS-M camera
(Photonic Science, Roberts Bridge, East Sussex, UK) and the resultant
analogic video signal from the camera was digitalized with an 8-bit
analogue-to-digital converter. Images were collected every 5 s for a
standard time of 5-6 min. Agonists were added directly to the perfu-
sion chamber immediately after recording the [Ca2]ij basal value.
[Ca2+]i was calculated using "Tardis" software (Joyce Loebl, Newcas-
tle, UK) after the creation ofratio images (340:380) by dividing original
images from which the background (cell removed) had been subtracted
on a pixel-to-pixel basis. The calibration was performed according to
Cheung et al. (14), calculating A, Rn,,,,, and R,., for each preparation
and using a Kd for Fura-2 of 224 according to Grynkiewics et al. (15).
To measure cell area, spatial calibration was performed by measuring
division on a graticule under the same optical conditions as the rest of
the experiments.
Results and Discussion
Fig. 1 illustrates the changes in [Ca2+]i induced by exposure of
human FSC monolayers to THR, All, and ET- I in a series of
representative experiments. For all agonists tested, the onset of
responses was virtually immediate and peak increments of
[Ca2+]i, over a resting level of 90-100 nM, were transiently
reached within 15-20 s, declining rapidly to a sustained phase
which was maintained for several minutes. When otherwise
identical experiments were performed in virtual absence ofex-
tracellular calcium ([Ca2-`) the peak height of the calcium
transient induced by all agonists was reduced on average by
5-10% and the sustained phase was almost completely abro-
gated. These observations indicate that the peak effect induced
by these vasoconstrictors is mainly due to intracellular release
of Ca2+ from cytosolic stores, whereas the sustained phase de-
pends on stimulated influx. In the presence of 1.0 mM [Ca2k]e
the sustained phase induced by exposure to THR and All was
abolished by pretreating cell monolayers with two different
membrane Ca2+ channel blockers, namely bepridil (a pheneth-
ylamine type ofCa2' channel blocker) and nifedipine (a 1 ,4-di-
hydropyridine type of Ca2+ channel blocker), suggesting that
the stimulated entry ofextracellular calcium responsible for the
sustained phase is likely due to the opening of voltage-depen-
dent transmembrane Ca2+ channels. Indeed, the two Ca2+
channel blockers used, belonging to series with different molec-
ular structure, have been shown to specifically block the same
putative voltage-sensitive Ca21 channels (16). Conversely, pre-
treatment with nifedipine or bepridil did not affect the sus-
tained phase induced by exposure to ET-l in the presence of
1.0 mM [Ca2J]i failing to support a role for voltage-dependent
Ca2+ channels or, at least, for those phenethylamine- and 1.4-
dihydropyridine-sensitive.
In Fura-2-loaded human FSC monolayers the [Ca2+]i in-
crease induced by THR, All, and ET- I was dose-dependent as
shown in Fig. 2.
The results of this first set of experiments indicated that
human FSC respond to local vasoconstrictor agonists with a
rapid increase in [Ca2+]i as other perivascular contractile cells.
In addition, the morphology and the dynamics of [Ca2+]i, and
the pharmacological effects ofvoltage-dependent Ca2" blockers
for the three agonists used, are similar to those previously
shown in smooth muscle cells (17), and in other organ-specific
pericytes such as glomerular mesangial cells (18-21).
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Figure 1. Changes in cytosolic free
calcium concentration ([Ca2+]i) in-
duced by exposure of Fura-2-loaded
human FSC monolayers to different
vasoconstrictor agonists. Human
FSC monolayers were loaded with
Fura-2-AM as described in Methods.
(A) Addition ofthrombin at a final
concentration of 5.0 NIH units/ml
induced a rapid [Ca(j] peak incre-
ment followed by a sustained phase
lasting several minutes. This plateau
was virtually abolished by repeating
the experiments in the absence of
extracellular calcium ([Ca2"],) with
or without pretreatment with 3.0
mM EGTA. Similarly, the sustained
phase was abolished by pretreating
the cells with 10-6 M bepridil, a
phenethylamine type of calcium
channel blocker, in the presence of
1.0 nM [Ca2'J%. Similar results were
obtained pretreating the cells with
10 MM nifedipine, a dihydropyri-
dine-sensitive Ca2" channel blocker
(not shown). (B) Similar [Ca2+]i in-
creases were induced by the addition
ofangiotensin II at a final concen-
tration of 0.1 MM. Analogously, the
sustained phase was abolished either
by performing the experiment in
the virtual absence of [Ca2"], or by
pretreating the cells with 10 M ni-
fedipine. (C) Addition of 0.1 M
endothelin- I induced analogous
[Ca2]i increases with abrogation of
the sustained phase in the absence
of [Ca2`],. However, both nifedipine
and bepridil were ineffective in
abolishing the sustained phase.
Since an elevation of [Ca2J]i in smooth muscle cells results
in activation of contractile proteins (22) and FSC have been
hypothesized to play a role in the local regulation ofsinusoidal
hemodynamics, we have also analyzed cell contractility in re-
sponse to the same agonists able to increase [Ca2+]i. For this
purpose we employed a dual wavelength, ratiometric video
imaging system that allows to study variations of [Ca2+]i along
with changes ofcell area in individual Fura-2-loaded cells. Sim-
ilarly to what was observed in the experiments performed using
cell monolayers, exposure ofindividual FSC to THR, AII, and
ET- 1 resulted in a rapid and transient increase of [Ca2J]i over a
resting level of 140-150 nM. When more than one cell per field
was observed, it was evident that the number of cells respond-
ing and the extent of response were variable, ranging from 0
(nonresponders) to 10-fold increase in [Ca2J]i. In addition, ago-
nist-induced Ca2+ transients did not begin simultaneously in
different cells but varied up to 60 s, indicating different activa-
tion times. Video-imaging analysis revealed that the increase of
[Ca2+]i begins in discrete areas located at the cell periphery,
particularly in the branching processes, with subsequent
spreading to the cell cytoplasm, often with a typical "calcium
wave" pattern. Among the three agonists tested, THR was the
most effective in terms of the number of responding cells and
extent of [Ca2"Ji increase. Indeed, a clear response was ob-
served in 20 out of the 24 cell cells analyzed, with an average
delta increase of - 600 nM. Fig. 3 shows four selected time-se-
quence frames from a representative experiment performed
using 0.3 NIH units ofTHR. By analyzing the frame-to-frame
variations of cell area versus the changes of [Ca2+]i (Fig. 4) it
was evident that the calcium increase induced by THR was
coupled with a simultaneous and transient reduction of cell
area, indicating reversible cell contraction. Similarly, reversible
changes of cell area coupled with [Ca2+]i increases (more than
fourfold) were observed when FSC were stimulated with both
ET- 1 and AII, although the number ofresponding cells and the
extent of response were lower than those induced by THR.
In summary, the results of this study demonstrate that in
human FSC vasoconstrictor agonists induce intracellular cal-
cium transients coupled with cell contraction analogously to
what was observed in other better characterized pericytes. Al-
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Figure 2. Dose-response curves for the effect of different vasoconstrictor agonists on [Ca,]i peak increase in monolayers ofFura-2-loaded human
FSC. Human FSC monolayers were loaded with Fura-2 as described in Methods. (A) Thrombin. (B) Angiotensin II. (C) Endothelin- 1. Data are
means±SD for three individual determinations.
though the in vivo biologic relevance of these observations re-
mains speculative, the results of this in vitro study strongly
support the hypothesis that FSC, beyond their morphological
appearance, may function as perisinusoidal contractile cells.
The presence ofa functionally active contractile apparatus en-
circling the sinusoids suggests that these vascular structures
might constitute a major regulatory site of intrahepatic- blood
flow. The responses induced in FSC by endothelium-derived
Figure 3. Time-sequence changes in intracellular calcium concentration in a single Fura-2-loaded human FSC responding to 0.3 NIH units/ml of
thrombin (representative experiment). Fura-2 loading and experimental procedures are described in Methods. Frame number and time(s) after
the addition ofthe agonist are shown in the left lower corner ofeach frame. Frame 3 (0.0 s) shows resting levels of [Ca+2]i. Frame 25 (61.4 s) shows
that increase in [Ca+2]i (indicated by the shift from green-blue to orange-red) starts at the cell periphery and rapidly progresses through the cyto-
plasm (frame 33, 79.4 s) as a "calcium wave." Frame 43 (101.9 s) shows the progressive return to basal values. Note the reduction of cell area
associated with the increase in [Ca2]i.





















Figure 4. Increase in intracellular calcium concentration [Ca2"i is
coupled with reversible cell contraction in an individual Fura-2-
loaded human FSC. Data from the same representative experiment
shown in Fig. 3. 0.3 NIH units/ml thrombin were added at the time
point indicated by the black arrow. Ratio frames were collected every
5 s. Closed circles, [Ca2i] nM; open circles, cell area RM2.
mediators, such as ET- 1 and AII, raise the possibility of a local
regulation of sinusoidal resistance operated by FSC-sinusoidal
endothelium interactions.
It should be noted, however, that early passaged human
FSC, as those employed in the present study, are characterized
by an "activated" phenotype resembling "transitional" or
"myofibroblast-like" cells rather than quiescent FSC retaining
the original "storing" phenotype. This phenotypical transition,
normally observed in cultures on plastic or glass (23) and in
vivo during active fibrogenesis (24), is characterized by a pro-
gressively more intense staining for a-smooth muscle actin
(25). Myofibroblast-like cells with prominent a-smooth muscle
actin filaments have been described in fibrous septa, around
sinusoids, and terminal hepatic venules of cirrhotic livers (26).
In this clinical condition they are believed to be responsible for
the contraction of maturing scar tissue and to contribute, by
maintaining a contractile state, to the increased resistance to
portal flow (27). Although the relevance of our findings to the
situation in normal liver remains to be established, they are
likely to be more representative of FSC contractile status in
fibrotic liver. The potent effect ofTHR described in this study
provides an example of the effect of vasoconstricting agents
possibly involved in this process. In conclusion, our observa-
tions open new perspectives in the interpretation of mecha-
nisms regulating intrahepatic blood flow and may contribute to
the development of pharmacological strategies able to affect
intrasinusoidal blood pressure.
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